Buy Invokana Online

Invokana is a once-daily tablet medicine containing canagliflozin, an SGLT2 inhibitor used in adults with type 2 diabetes. You can buy Invokana online, view current pricing, and choose the available strength that matches your clinician’s directions. BorderFreeHealth offers US delivery from Canada for customers seeking a cash-pay option through licensed pharmacy channels.

Invokana Price, Strengths, and Ordering

Invokana price can vary by strength, quantity, supplier, and country-of-origin sourcing. During ordering, review the current cash price for the available tablet strength and make sure the dose, quantity, and directions match the treatment plan you were given. This is especially important when comparing Invokana 100mg price, Invokana 300mg price, and canagliflozin price across cash-pay choices.

Invokana is supplied as film-coated tablets. The commonly referenced strengths are 100 mg tablets and 300 mg tablets. Availability may differ by supplier and pack size, so use the strength shown at checkout rather than assuming a specific quantity or presentation.

Quick tip: If you are planning a multi-month fill, confirm the tablet strength and refill timing before you run low.

Many people look for Invokana cost out of pocket because insurance coverage, deductibles, and pharmacy networks can change the amount they pay. A cash-pay Canadian pharmacy route may be useful for budget planning, but the right medication choice still depends on your medical history, kidney function, and treatment goals.

What Invokana Treats

Invokana is used with diet and exercise to improve blood sugar control in adults with type 2 diabetes. Type 2 diabetes is a chronic condition in which the body does not use insulin effectively, causing blood glucose to remain higher than the body can safely handle over time.

Canagliflozin may also be used in certain adults with type 2 diabetes and established cardiovascular disease to reduce the risk of major cardiovascular events. The label also includes kidney-related use in appropriate adults with diabetic kidney disease. These benefits are patient-specific, so kidney function, heart history, blood pressure, and other medicines all matter when deciding whether this SGLT2 inhibitor fits your care plan.

This medicine is not for treating type 1 diabetes or diabetic ketoacidosis. Diabetic ketoacidosis is a serious condition in which acids called ketones build up in the blood. It can happen even when blood sugar is not extremely high, so symptoms such as nausea, vomiting, stomach pain, unusual tiredness, or trouble breathing need urgent medical attention.

For broader condition education, the Type 2 Diabetes section explains common treatment goals and monitoring topics. You can also browse the type 2 diabetes articles for practical background on blood sugar management.

How Canagliflozin Works

Invokana belongs to a class called sodium-glucose cotransporter 2 inhibitors, often shortened to SGLT2 inhibitors. These medicines work in the kidneys. They reduce reabsorption of glucose, allowing more sugar to leave the body through urine.

Because the medicine increases urinary glucose excretion, you may urinate more often or feel thirstier, especially when starting therapy. Fluid loss can contribute to dizziness, low blood pressure, or dehydration in some people. Drinking fluids regularly, unless told otherwise by a clinician, can help reduce avoidable problems.

The kidney-based mechanism also explains why kidney function is monitored. If kidney function is too low, the glucose-lowering effect may be reduced and safety concerns may increase. Lab monitoring can include estimated glomerular filtration rate, electrolytes, and A1C, depending on your overall health.

How to Take Invokana Tablets

Invokana is typically taken by mouth once daily, preferably before the first meal of the day. Your clinician may use a lower starting strength and adjust the plan based on kidney function, glucose goals, and how well you tolerate therapy. Do not change the dose on your own.

If you miss a dose, take it when remembered on the same day. If it is almost time for the next dose, skip the missed dose and return to the usual schedule. Taking two doses at once can raise the chance of side effects and should be avoided.

If Invokana is used with insulin or a sulfonylurea, low blood sugar may be more likely. Symptoms of hypoglycemia can include sweating, shaking, hunger, confusion, fast heartbeat, or weakness. Your care plan may include glucose checks, food timing, and adjustment of other diabetes medicines to reduce that risk.

Benefits and Realistic Expectations

Invokana can help lower A1C when used consistently with nutrition, activity, and other parts of a diabetes plan. Some people may also notice modest weight reduction because glucose calories leave the body in urine. Weight changes vary, and this medication should not be viewed as a stand-alone weight-loss treatment.

For eligible adults with type 2 diabetes and certain heart or kidney risks, canagliflozin has label-supported benefits beyond glucose lowering. Those benefits do not apply equally to everyone. Your clinician may weigh cardiovascular history, kidney markers, infection risk, foot health, blood pressure, and hydration status before continuing long-term treatment.

Many people reassess therapy after follow-up labs. A1C trends, home glucose readings, kidney function, blood pressure, side effects, and daily adherence all help determine whether the medicine is working well enough for the risks and cost.

Side Effects, Warnings, and Monitoring

Common side effects of Invokana include increased urination, thirst, genital yeast infections, urinary tract infections, nausea, constipation,

dizziness. These effects are often connected to the way SGLT2 inhibitors increase glucose and fluid loss through urine.

Serious adverse effects can occur. The label warns about diabetic ketoacidosis, acute kidney injury, serious urinary infections, low blood pressure from volume depletion, high potassium, bone fractures, and rare but severe genital or perineal infections. Canagliflozin has also been associated with an increased risk of lower-limb amputation in some patients, especially those with prior amputation, peripheral vascular disease, neuropathy, or diabetic foot ulcers.

Seek urgent care for symptoms such as severe weakness, vomiting, trouble breathing, confusion, fever, severe genital pain, signs of spreading infection, or a foot wound that worsens. Stop-and-start decisions should be made with medical guidance, particularly around surgery, fasting, severe illness, or dehydration.

Before using this medicine, discuss kidney disease, liver disease, recurrent urinary or genital infections, low blood pressure, diuretic use, amputation history, neuropathy, foot ulcers, and pregnancy or breastfeeding. Monitoring may include kidney labs, electrolytes, glucose readings, A1C, blood pressure, and regular foot checks.

Drug Interactions and Use Cautions

Tell your clinician about all medicines, vitamins, and supplements you take. Diuretics, sometimes called water pills, can increase the risk of dehydration or low blood pressure when combined with canagliflozin. Blood pressure medicines and medicines that affect kidney function may also require closer monitoring.

Insulin and sulfonylureas can increase the chance of hypoglycemia when used with Invokana. Certain enzyme-inducing medicines, such as rifampin or phenytoin, may reduce canagliflozin exposure. Digoxin levels may increase when used with canagliflozin, so monitoring may be needed if you take digoxin.

Invokana should not be used during active diabetic ketoacidosis. People with severe kidney impairment, dialysis, or a serious hypersensitivity reaction to canagliflozin should avoid it unless a clinician determines otherwise under the product label and their clinical judgment.

Storage, Travel, and Shipping

Store Invokana tablets at room temperature in a dry place. Keep the bottle tightly closed and away from excess moisture, heat, children, and pets. Bathrooms are usually poor storage locations because humidity can affect tablets over time.

When traveling, keep tablets with the labeled container so the medicine can be identified. Bring enough for the trip and avoid leaving the bottle in a hot car, checked luggage exposed to temperature extremes, or any place where the tablets could become wet.

Invokana does not require pen handling, needles, injection training, or sharps disposal. Orders may be sent with prompt, express shipping when logistics and product handling requirements allow.

Invokana Compared With Other Diabetes Options

Invokana is one option within the SGLT2 inhibitor class. Other medicines in the class may have different labeled indications, dosing details, side effect profiles, and insurance or cash-pay costs. A clinician may consider heart failure, kidney disease, A1C target, blood pressure, infection history, and drug interactions when choosing among SGLT2 inhibitors.

Some diabetes medicines work through different mechanisms. DPP-4 inhibitors, GLP-1 receptor agonists, insulin, metformin, and sulfonylureas affect glucose in other ways. The best fit may depend on whether the main goal is A1C lowering, kidney protection, cardiovascular risk reduction, weight management, avoidance of hypoglycemia, or simplicity of dosing.

To browse related treatment categories, visit Diabetes Care. If weight goals are part of your plan, the Weight Management category can help you understand adjacent therapy areas to discuss with your clinician.

Brand, Generic, and Country-of-Origin Notes

Invokana is the brand name for canagliflozin. In some markets, brand and generic naming, approval status, and product sourcing can differ. When reviewing Invokana generic price or canagliflozin tablets price, focus on the exact active ingredient, strength, manufacturer, and product shown during checkout.

Country-of-origin filters can help you understand sourcing choices without changing the medical questions that matter. You can browse products associated with Canada or India when those filters are relevant to your shopping preferences.

Do not substitute a different diabetes medicine simply because it appears less expensive. SGLT2 inhibitors, DPP-4 inhibitors, GLP-1 medicines, and insulin products are not interchangeable without clinical review. Even medicines in the same class can differ in labeled uses, dose adjustments, and safety considerations.

Questions to Discuss Before Long-Term Use

• Is canagliflozin appropriate for my kidney function and A1C goal?
• Do my heart or kidney risks make this medicine especially relevant?
• How often should I check glucose, blood pressure, and lab work?
• What symptoms of ketoacidosis, dehydration, or infection require urgent care?
• Could my diuretic, insulin, sulfonylurea, digoxin, or seizure medicine interact?
• What foot care steps should I follow while taking this medicine?
• Should I pause therapy before surgery, fasting, or severe illness?

Authoritative Sources

Official prescribing information

MedlinePlus canagliflozin drug information

Health Canada product record

This content is for informational purposes only and is not a substitute for professional medical advice.